⌘K

16:27:23·70d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Design Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.

DSGN· Design Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

DSGN
Design Therapeutics Inc.
Health Care

Recent analyst ratings

Mar 16UpdateJefferies$15.00
Jan 7UpdateOppenheimer$18.00
Dec 3UpdateLeerink Partners$14.00
Dec 3UpdateCraig Hallum$15.00
Nov 20UpdateRBC Capital Mkts$13.00
May 7UpdatePiper Sandler$12.00

Related

SEC8h
SEC Form 10-Q filed by Design Therapeutics Inc.
SEC8h
Design Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
PR8h
Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
SEC5d
SEC Form DEFA14A filed by Design Therapeutics Inc.
SEC5d
SEC Form DEF 14A filed by Design Therapeutics Inc.
INSIDER27d
SEC Form 4 filed by Shapiro David
INSIDER27d
SEC Form 3 filed by new insider Shapiro David
SEC27d
Design Therapeutics Inc. filed SEC Form 8-K: Leadership Update